Projects / Programmes
Structural-based neutralization of endotoxin by peptides
Code |
Science |
Field |
Subfield |
1.09.00 |
Natural sciences and mathematics |
Pharmacy |
|
Code |
Science |
Field |
B470 |
Biomedical sciences |
Physiology |
LPS; immune response, peptidic inhibitors of LPS; molecular recognition; rational drug design
Researchers (8)
no. |
Code |
Name and surname |
Research area |
Role |
Period |
No. of publicationsNo. of publications |
1. |
18675 |
Robert Bremšak |
|
Technician |
2004 - 2007 |
11 |
2. |
17915 |
PhD Helena Gradišar |
Biotechnical sciences |
Researcher |
2004 - 2006 |
125 |
3. |
23940 |
PhD Boštjan Japelj |
Natural sciences and mathematics |
Junior researcher |
2004 - 2007 |
37 |
4. |
06628 |
PhD Roman Jerala |
Natural sciences and mathematics |
Researcher |
2004 - 2007 |
1,141 |
5. |
17917 |
PhD Andreja Majerle |
Biotechnical sciences |
Researcher |
2004 - 2007 |
92 |
6. |
12048 |
PhD Marjetka Podobnik |
Natural sciences and mathematics |
Researcher |
2007 |
291 |
7. |
12060 |
PhD Primož Pristovšek |
Natural sciences and mathematics |
Principal Researcher |
2004 - 2007 |
135 |
8. |
22575 |
PhD Primož Šket |
Natural sciences and mathematics |
Researcher |
2007 |
211 |
Organisations (1)
no. |
Code |
Research organisation |
City |
Registration number |
No. of publicationsNo. of publications |
1. |
0104 |
National Institute of Chemistry |
Ljubljana |
5051592000 |
21,093 |
Abstract
Lipopolysaccharide (LPS) triggers a series of defense reaction in the body that may lead to septic shock which is a leading cause of death in intensive care units and according to estimates, causes in the European union more than 150.000 casualties annually. One of the important strategies of preventing sepsis is aimed at its neutralization by specific binding of peptides that are derived from natural defense proteins or peptides. In continuation of our previous work where we have determined the bound tertiary structures of a series of peptides we will study additional structural aspects of LPS binding to peptidic inhibitors. We will determine the peptide stuctures when bound to LPS using NMR techniques while we approach the structures of the complex using computer modeling. We plan to refine the pharmacophore - the common LPS binding motif that we have already extended in our previous work by evaluating besides electrostatic also hydrophobic interactions. The course of action will include repeated cycles of designing new peptides with altered properties, their synthesis, structure analysis and determination of their characteristics, e.g. binding of LPS (Kd), neutralization of cell activation by LPS and any toxicity towards human cells. All the necessary equipment and knowledge for the execution of such a complex task is available in the research group. We expect that the project will provide the basis for rational design of novel peptide inhibitors of LPS activity.